GILEAD SCIENCES, INC.
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | RCUS | 31.42M | $427.38M |
 | GLPG | 16.71M | $578.75M |
 | XLO | 9.11M | $7.67M |
 | ACLX | 6.72M | $551.78M |
 | LPTX | 5.32M | $2.41M |
 | TNGX | 4.85M | $40.78M |
 | ASMB | 4.51M | $115.34M |
 | KYTX | 4.13M | $24.76M |
 | MRUS | 453K | $42.61M |
Arcus Biosciences, Inc.
RCUS
Shares Held
31.42M
Value
$427.38M
Galapagos N.V.
GLPG
Shares Held
16.71M
Value
$578.75M
Xilio Therapeutics, Inc.
XLO
Shares Held
9.11M
Value
$7.67M
Arcellx, Inc.
ACLX
Shares Held
6.72M
Value
$551.78M
Leap Therapeutics, Inc.
LPTX
Shares Held
5.32M
Value
$2.41M
Tango Therapeutics, Inc.
TNGX
Shares Held
4.85M
Value
$40.78M
Assembly Biosciences, Inc.
ASMB
Shares Held
4.51M
Value
$115.34M
Kyverna Therapeutics, Inc.
KYTX
Shares Held
4.13M
Value
$24.76M
Merus N.V.
MRUS
Shares Held
453K
Value
$42.61M